| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | KY72JU32FO |
| InChI Key | BFZKMNSQCNVFGM-UCEYFQQTSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C30H41NO6S |
| Molecular Weight | 543.73 |
| AlogP | 5.46 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 109.25 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 38.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| STABILISER | Tubulin stabiliser | PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Glioblastoma | 2 | D005909 | ClinicalTrials |
| Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Ovarian Neoplasms | 2 | D010051 | ClinicalTrials |
| Central Nervous System Neoplasms | 2 | D016543 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 305841-29-6 |
| ChEMBL | CHEMBL2304041 |
| DrugBank | DB12391 |
| FDA SRS | KY72JU32FO |
| PubChem | 11284169 |
| SureChEMBL | SCHEMBL423579 |
| ZINC | ZINC000003964449 |